This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Thu, 01/30/2025 - 15:31 Jan. 29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. For information please visit Reference: Bazan HA et al.
Stroke, Volume 56, Issue Suppl_1 , Page ANS8-ANS8, February 1, 2025. Background and Purpose:Patients discharged home after a stroke are particularly vulnerable during the immediate post-discharge period. Patients were seen by the outpatient stroke NP within 7 to 14 days, either in clinic or via telemedicine.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP82-AWMP82, February 1, 2025. Our Comprehensive Stroke Center identified critical gaps in post-discharge care, including inconsistent follow-up timing and a high rate of missed appointments.
Stroke, Volume 56, Issue Suppl_1 , Page AWP137-AWP137, February 1, 2025. Introduction:Many national initiatives have focused on increasing public awareness of acute ischemic stroke (AIS) symptoms because earlier treatment is associated with improved outcomes. 1.39]), Medicaid insurance (1.16 [1.06-1.27]),
Stroke, Volume 56, Issue Suppl_1 , Page AHUP8-AHUP8, February 1, 2025. Patients with safety-net features were those with Medicaid or no insurance. These findings support changes in resource allocation and efforts to improve the care of ischemic stroke in SNHs. 1.19), acute respiratory failure (aOR 1.24, 95% CI 1.20-1.29),
Stroke, Volume 56, Issue Suppl_1 , Page ATP132-ATP132, February 1, 2025. Patients with safety-net features were those with Medicaid or no insurance. These findings support changes in resource allocation and efforts to improve the care of ischemic stroke in SNHs. 1.19), acute respiratory failure (aOR 1.24, 95% CI 1.20-1.29),
Stroke, Volume 56, Issue Suppl_1 , Page ATP328-ATP328, February 1, 2025. We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data. Objective:The role of statins in the management of intracerebral hemorrhage (ICH) remains controversial.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP58-AWMP58, February 1, 2025. Introduction:The management of acute ischemic stroke over the last three decades has seen an expansive progression in terms of medical and surgical interventions. 4.42, p<0.02). 3.06, p<0.04). 3.82, p<0.01).
Stroke, Volume 56, Issue Suppl_1 , Page AWP235-AWP235, February 1, 2025. Disparities in outcomes of patients with ischemic stroke have been associated with insurance coverage. Introduction:Insurance status may serve as an indicator of social and financial barriers that impede access to quality care. 2.03, p=0.022, Figure 1).
tim.hodson Mon, 01/27/2025 - 09:47 Jan. Hypertension, or high blood pressure, impacts more than1 billion adults worldwide, and is the leading modifiable cause of heart attack, stroke, and death. FDA-approved breakthrough device. 5-8 The Symplicity RDN system is approved for commercial use in more than 75 countries around the world.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content